ALLN-346 Single Ascending Dose (SAD) Study in Healthy Volunteers
Clinical trial NCT04236219 · COMPLETED
Trial details
- NCT number
- NCT04236219
- Sponsor
- Allena Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-02
- Primary completion
- 2020-11-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.